サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1490235

ナノ医薬品市場：製品タイプ別、用途別、流通経路別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測

Nanopharmaceuticals Market, By Product Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 284 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
ナノ医薬品市場：製品タイプ別、用途別、流通経路別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ナノ医薬品市場規模は2023年に698億7,109万米ドルとなり、2024～2032年にかけて14.91%のCAGRで拡大

ナノ医薬品市場-市場力学

がんと神経疾患の有病率の増加が市場成長を牽引すると予測

ナノ医薬品市場は、がんと神経疾患の有病率の増加により、大きな成長が見込まれます。このような高度な治療ソリューションに対する需要の高まりは、ナノ技術が提供する独自の利点が原動力となっています。The Lancet Neurologyによると、2021年には世界で30億人以上が神経疾患とともに生活しています。WHOは、Global Burden of Disease, Injuries, and Risk Factor Study（GBD）2021データの精査に寄付しています。さらに、研究開発活動の継続的な成長と技術の進歩により、市場は恩恵を受けると予想されます。しかし、安全性と毒性に関する懸念が市場の成長を妨げる可能性があります。

ナノ医薬品市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約14.91%のCAGRで毎年成長すると推定されます。

製品タイプ別では、リポソームが2023年に最大の市場シェアを示すと予測されています。

用途別セグメントでは、2023年にがんが主要タイプでした。

流通チャネル別では、2023年に製薬会社が主要タイプでした。

地域別では、北米が2023年に収益を生み出す主要市場となっています。

ナノ医薬品市場-セグメンテーション分析：

ナノ医薬品の世界市場は、製品タイプ、用途、流通チャネル、地域に基づいてセグメント化されます。

市場は製品タイプによって5つのグループに区分される：リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョン、ナノエマルジョン、その他です。リポソームは、ドラッグデリバリーにおける数々の利点から、市場をリードするカテゴリーです。リポソームは、親水性薬剤と疎水性薬剤の両方をカプセル化し、溶解性と安定性を高めることができます。さらに、リポソームは体内の特定部位を対象として薬剤を放出するようにカスタマイズできるため、全身的な副作用を最小限に抑えることができます。

市場は用途によって4つのカテゴリーに分類される：がん、自己免疫疾患、炎症、その他です。がんセグメントが最大の市場シェアを占めています。ナノ医薬品は、腫瘍のタイプ、遺伝的体質、疾患の進行度など、特定の患者の属性に合わせて薬剤製剤をカスタマイズすることで、オーダーメイドのがん治療の可能性を提示します。

市場は流通チャネルによって3つのセグメントに分類される：製薬会社、バイオテクノロジー企業、研究機関です。市場を独占しているのは製薬会社です。これらの企業は、革新的なナノ医薬品製剤を生み出すための研究開発（R&D）に多大なリソースを割いています。これには、ドラッグデリバリーを強化し治療成果を向上させるための、新規ナノ材料、カプセル化技術、ターゲティング戦略の探求が含まれます。

ナノ医薬品市場-地理的洞察

市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに地理的に広がっており、各地域はさらに国別に分かれています。北米は、医薬品へのナノ技術の応用に関する研究開発の増加により、市場の成長をリードしています。特に米国は、ナノ技術研究の最前線に位置するトップレベルの研究機関、大学、バイオテクノロジー企業の本拠地です。米国はナノ技術市場を独占しており、2018年の世界市場収益の38％以上を占めています。その結果、北米はナノ技術セグメントで最大のシェアを占め、40％以上を占めています。ナノ技術産業統計によると、エネルギー用途のナノ技術市場は2024年までに85億米ドルに達すると予測されています。欧州は、慢性疾患の蔓延に起因する市場成長の第2位の地域です。

ナノ医薬品市場-競合情勢：

ナノ医薬品市場のメーカーには、強力な研究開発能力と世界の事業展開力を持つ大手製薬企業が含まれます。これらの企業はナノ医薬品の研究開発に積極的に取り組んでおり、創薬と商業化の専門知識を活用して、ナノ技術によるドラッグデリバリーシステムを進化させています。この市場の競合は激しく、各社は独占的なナノキャリア技術の獲得、先進的な製剤の開発、がん、感染症、中枢神経障害などの主要治療セグメントにおける市場プレゼンスの拡大を競っています。ナノ医薬品市場の競合情勢は多様で、既存製薬企業、革新的新興企業、ナノ技術企業、学術機関、開発・製造受託機関（CDMO）、規制機関などが含まれます。

目次

第1章 ナノ医薬品市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ナノ医薬品の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ナノ医薬品産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 ナノ医薬品市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 ナノ医薬品市場情勢

  • ナノ医薬品市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ナノ医薬品市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • リポソーム
    • 高分子ミセル
    • 固体脂質ナノ粒子
    • マイクロエマルジョン
    • ナノエマルジョン
    • その他

第8章 ナノ医薬品市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • がん
    • 自己免疫疾患
    • 炎症
    • その他

第9章 ナノ医薬品市場-流通チャネル別

  • 概要
    • 流通チャネル別セグメントシェア分析
    • 製薬会社
    • バイオテクノロジー企業
    • 研究機関

第10章 ナノ医薬品市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-ナノ医薬品業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Merck
    • Pfizer
    • Novartis
    • Abbott
    • GlaxoSmithKline
    • Roche
    • Sanofi
    • Eli Lilly
    • Astrazeneca
    • Johnson &Johnson
    • Celgene
    • Novavax
    • Stryker
    • Gilead Sciences
    • OSI Pharmaceuticals
    • Kadmon Pharmaceuticals
    • Samyang Biopharm
    • Mitsubishi Pharma
    • Kaken Pharmaceutical
    • Selecta Biosciences
    • Par Pharmaceutical
    • Cerulean Pharma
    • Navidea Biopharmaceuticals
    • Lummy
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanopharmaceuticals Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Nanopharmaceuticals Market, by Product Type 2019-2032 (USD Million)
  • TABLE Nanopharmaceuticals Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanopharmaceuticals Market, by Application 2019-2032 (USD Million)
  • TABLE Nanopharmaceuticals Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Nanopharmaceuticals Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Nanopharmaceuticals Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanopharmaceuticals Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanopharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanopharmaceuticals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Nanopharmaceuticals Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Nanopharmaceuticals Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Nanopharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanopharmaceuticals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Nanopharmaceuticals Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanopharmaceuticals Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanopharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanopharmaceuticals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanopharmaceuticals Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanopharmaceuticals Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Nanopharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanopharmaceuticals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanopharmaceuticals Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanopharmaceuticals Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanopharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanopharmaceuticals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanopharmaceuticals Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanopharmaceuticals Market, by Distribution Channel, 2019-2032 (USD Million)
目次
Product Code: ANV2809

REPORT HIGHLIGHT

The Nanopharmaceuticals Market size was valued at USD 69,871.09 million in 2023, expanding at a CAGR of 14.91% from 2024 to 2032.

Nanopharmaceuticals represent an innovative field within pharmaceutical science that utilizes nanotechnology for drug development and delivery. By targeting specific cells or tissues, nanopharmaceuticals enhance drug concentration at the intended site of action while reducing adverse effects on healthy tissues. This precise drug delivery is especially beneficial in cancer therapy, as nanoparticles can transport chemotherapy drugs directly to tumor cells. The utilization of nanopharmaceuticals signifies a state-of-the-art approach to drug administration and treatment, with the potential to transform the management of various medical conditions. Through continuous research, technological advancements, and progress in nanotechnology, nanopharmaceuticals are positioned to have a significant impact on the future of healthcare.

Nanopharmaceuticals Market- Market Dynamics

The increasing prevalence of cancer and neurological diseases is anticipated to drive the market growth

The nanopharmaceuticals market is projected to experience significant growth due to the increasing prevalence of cancer and neurological diseases. This rise in demand for advanced therapeutic solutions is driven by the unique advantages offered by nanotechnology. According to The Lancet Neurology, over 3 billion individuals worldwide were living with a neurological condition in 2021. The (WHO donated to the scrutiny of the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021 data. Additionally, the market is expected to benefit from the continuous growth in research and development activities and technological advancements. However, concerns regarding safety and toxicity may hinder the growth of the market.

Nanopharmaceuticals Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.91% over the forecast period (2024-2032)

Based on product type segmentation, Liposomes were predicted to show maximum market share in the year 2023

Based on application segmentation, Cancer was the leading type in 2023

Based on Distribution Channel segmentation, Pharmaceutical Companies was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Nanopharmaceuticals Market- Segmentation Analysis:

The Global Nanopharmaceuticals Market is segmented based on Product Type, Application, Distribution Channel, and Region.

The market is segmented into five groups according to product type: Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion, Nanoemulsion, and Others. Liposomes are the leading category in the market due to their numerous benefits in drug delivery. They can encapsulate both hydrophilic and hydrophobic drugs, enhancing their solubility and stability. Moreover, liposomes can be customized to target specific areas in the body for drug release, thereby minimizing systemic side effects.

The market is segmented into four categories according to their application: Cancer, Autoimmune Disorders, Inflammation, and Other. The Cancer segment holds the largest market share. Nanopharmaceuticals present possibilities for tailored cancer therapy through the customization of drug formulations tailored to specific patient attributes, including tumor type, genetic makeup, and disease progression.

The market is categorized into three segments according to the Distribution Channel: Pharmaceutical Companies, Biotechnological Companies, and Research Institutes. The dominant force in the market is the Pharmaceutical Companies. These companies allocate significant resources toward research and development (R&D) to create innovative nanopharmaceutical formulations. This entails the exploration of novel nanomaterials, encapsulation techniques, and targeting strategies to enhance drug delivery and improve therapeutic outcomes.

Nanopharmaceuticals Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further divided by nations. North America leads in market growth, driven by increased research and development in the application of nanotechnology in pharmaceuticals. The United States, in particular, is home to top research institutions, universities, and biotech companies at the forefront of nanotechnology research. The United States dominates the nanotechnology market, contributing more than 38% of global market revenue in 2018. As a result, North America holds the largest share of the nanotechnology sector, accounting for over 40%. The market for nanotechnology in energy applications is projected to reach USD 8.5 billion by 2024, according to Nanotechnology Industry Statistics. Europe follows as the second-largest region for market growth, attributed to the prevalence of chronic diseases.

Nanopharmaceuticals Market- Competitive Landscape:

Manufactures in the Nanopharmaceuticals market include leading pharmaceutical companies with strong research and development capabilities and a global footprint. These companies are actively involved in the research and development of nanopharmaceuticals, leveraging their expertise in drug discovery and commercialization to advance drug delivery systems based on nanotechnology. Competition in this market is intense, with companies vying for exclusive nanocarrier technologies, developing advanced formulations, and expanding their market presence in key therapeutic areas like oncology, infectious diseases, and central nervous system disorders. The competitive landscape of the nanopharmaceuticals market is diverse, encompassing established pharmaceutical firms, innovative startups, nanotechnology companies, academic institutions, contract development and manufacturing organizations (CDMOs), and regulatory bodies.

Recent Developments:

The UK technology innovation provider for process manufacturing, the Centre for Process Innovation (CPI), has revealed today the initiation of a new collaborative project aimed at enhancing its nanoformulations capabilities. This move is intended to enhance CPI's ability to collaborate with companies in the development of cutting-edge nanomedicines.

Pfizer, the largest pharmaceutical company globally, has agreed to compensate privately owned Bind Therapeutics Inc. up to USD200 million for each potential drug to create medications utilizing its nanotechnology platform. The technology utilized by Bind originates from the research labs of Robert Langer, a senior lecturer on surgery at Boston Children's Hospital affiliated with MIT and HMS, as well as Omid Farokhzad, an associate professor of anesthesia at Brigham and Women's Hospital affiliated with HMS.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOPHARMACEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck

Pfizer

Novartis

Abbott

GlaxoSmithKline

Roche

Sanofi

Eli Lilly

AstraZeneca

Johnson & Johnson

Celgene

Novavax

Stryker

Gilead Sciences

OSI Pharmaceuticals

Kadmon Pharmaceuticals

Samyang Biopharm

Mitsubishi Pharma

Kaken Pharmaceutical

Selecta Biosciences

Par Pharmaceutical

Cerulean Pharma

Navidea Biopharmaceuticals

Lummy

Others

GLOBAL NANOPHARMACEUTICALS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Liposomes
  • Polymeric Micelles
  • Solid Lipid Nanoparticles
  • Microemulsion
  • Nanoemulsion
  • Other

GLOBAL NANOPHARMACEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Autoimmune Disorders
  • Inflammation
  • Other

GLOBAL NANOPHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnological Companies
  • Research Institutes

GLOBAL NANOPHARMACEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanopharmaceuticals Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanopharmaceuticals Market Snippet by Product Type
    • 2.1.2.Nanopharmaceuticals Market Snippet by Application
    • 2.1.3.Nanopharmaceuticals Market Snippet by Distribution Channel
    • 2.1.4.Nanopharmaceuticals Market Snippet by Country
    • 2.1.5.Nanopharmaceuticals Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanopharmaceuticals Key Market Trends

  • 3.1.Nanopharmaceuticals Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanopharmaceuticals Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanopharmaceuticals Market Opportunities
  • 3.4.Nanopharmaceuticals Market Future Trends

4.Nanopharmaceuticals Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanopharmaceuticals Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanopharmaceuticals Market Landscape

  • 6.1.Nanopharmaceuticals Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanopharmaceuticals Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Liposomes
    • 7.1.3.Polymeric Micelles
    • 7.1.4.Solid Lipid Nanoparticles
    • 7.1.5.Microemulsion
    • 7.1.6.Nanoemulsion
    • 7.1.7.Other

8.Nanopharmaceuticals Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cancer
    • 8.1.3.Autoimmune Disorders
    • 8.1.4.Inflammation
    • 8.1.5.Other

9.Nanopharmaceuticals Market - By Distribution Channel

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical Companies
    • 9.1.3.Biotechnological Companies
    • 9.1.4.Research Institutes

10.Nanopharmaceuticals Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Nanopharmaceuticals Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Nanopharmaceuticals Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Nanopharmaceuticals Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Nanopharmaceuticals Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Nanopharmaceuticals Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Nanopharmaceuticals Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Merck
    • 11.2.2.Pfizer
    • 11.2.3.Novartis
    • 11.2.4.Abbott
    • 11.2.5.GlaxoSmithKline
    • 11.2.6.Roche
    • 11.2.7.Sanofi
    • 11.2.8.Eli Lilly
    • 11.2.9.Astrazeneca
    • 11.2.10.Johnson & Johnson
    • 11.2.11.Celgene
    • 11.2.12.Novavax
    • 11.2.13.Stryker
    • 11.2.14.Gilead Sciences
    • 11.2.15.OSI Pharmaceuticals
    • 11.2.16.Kadmon Pharmaceuticals
    • 11.2.17.Samyang Biopharm
    • 11.2.18.Mitsubishi Pharma
    • 11.2.19.Kaken Pharmaceutical
    • 11.2.20.Selecta Biosciences
    • 11.2.21.Par Pharmaceutical
    • 11.2.22.Cerulean Pharma
    • 11.2.23.Navidea Biopharmaceuticals
    • 11.2.24.Lummy
    • 11.2.25.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us